TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35168963

Group type: EXPERIMENTAL
Intervention: Tailored multidimensional intervention (6 months duration, including three home visits, six home-based telephone calls, and one peer-support session)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Simple educational instructions at a single visit (control group)
Number of subjects: 110
Study: 32947415

Group type: EXPERIMENTAL
Intervention: Densitometry distribution analysis (DDA)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DDA
Number of subjects: 196

Group type: COMPARATOR
Intervention: Traditional corneal densitometry
Number of subjects: 196
Study: 32285238

Group type: EXPERIMENTAL
Intervention: Quality of Life Therapy (QOLT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Heart Healthy Education (HHE)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 21
Study: 33727257

Group type: EXPERIMENTAL
Intervention: mFOLFOX6 + aflibercept
Number of subjects: 180

Group type: COMPARATOR
Intervention: mFOLFOX6 - aflibercept
Number of subjects: 180
Study: 34672767

Group type: EXPERIMENTAL
Intervention: Dietary nitrate-rich beetroot juice (4.1mmol NO3-/day; DNS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Dietary nitrate-rich beetroot juice (DNS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study: 34018423

Group type: EXPERIMENTAL
Intervention: Broad-based male empowerment curriculum
Number of subjects: 580

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 580
Study: 32037644

Group type: EXPERIMENTAL
Intervention: Let's Talk about Children (Let's Talk) intervention
Number of subjects: 16
Study: 37225286

Group type: EXPERIMENTAL
Intervention: TEER plus GDMT
Number of subjects: 348

Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 348
Study: 33626254

Group type: EXPERIMENTAL
Intervention: xanomeline-trospium
Number of subjects: 182

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 182
Study: 33158079

Group type: EXPERIMENTAL
Intervention: 85 g of mango intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 250 g of mango intake
Number of subjects: 0
Study: 35079789

Group type: EXPERIMENTAL
Intervention: Dolutegravir/Lamivudine (DTG/3TC)
Number of subjects: 741

Group type: COMPARATOR
Intervention: Tenofovir Alafenamide-based regimen (TAF)
Number of subjects: 741
Study: 33933933

Group type: EXPERIMENTAL
Intervention: Elastic ankle support
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normal running (without ankle support)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ankle in-/eversion
Number of subjects: 27
Study: 33734099

Group type: EXPERIMENTAL
Intervention: Brief motivational interviewing intervention
Number of subjects: 86

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 86
Study: 32267058

Group type: EXPERIMENTAL
Intervention: Oral semaglutide 7 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral semaglutide 14 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sitagliptin (DPP-4 inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Empagliflozin (SGLT-2 inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liraglutide (subcutaneous GLP-1RA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dulaglutide (subcutaneous GLP-1RA)
Number of subjects: 0
Study: 32750212

Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration (FNA)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Core needle biopsy (CNB)
Number of subjects: 61
Study: 32456272

Group type: EXPERIMENTAL
Intervention: Metformin + MICT
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Metformin + high-volume HIIT
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Metformin + low-volume HIIT
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: No Metformin + MICT
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: No Metformin + high-volume HIIT
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: No Metformin + low-volume HIIT
Number of subjects: 99

Group type: COMPARATOR
Intervention: No Metformin
Number of subjects: 99

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 99
Study: 36321612

Group type: EXPERIMENTAL
Intervention: Post-PCI vFFR
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Post-PCI FFR
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Correlation between vFFR and FFR
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: vFFR predicting FFR <0.90
Number of subjects: 50
Study: 34407884

Group type: EXPERIMENTAL
Intervention: cCBT
Number of subjects: 100

Group type: COMPARATOR
Intervention: UC
Number of subjects: 100
Study: 36376888

Group type: EXPERIMENTAL
Intervention: Venetoclax combined with low dose cytarabine (VEN + LDAC)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Standard of care intensive chemotherapy (IC)
Number of subjects: 156
Study: 32242215

Group type: EXPERIMENTAL
Intervention: Pleasant Events Program (PEP)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Information and Support (IS)
Number of subjects: 123
Study: 36152639

Group type: EXPERIMENTAL
Intervention: Tirzepatide (5 mg, 10 mg, or 15 mg)
Number of subjects: 2002

Group type: COMPARATOR
Intervention: Insulin glargine (100 U/mL)
Number of subjects: 2002

Group type: EXPERIMENTAL
Intervention: Tirzepatide
Number of subjects: 2002

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 2002
Study: 34810346

Group type: EXPERIMENTAL
Intervention: Pinwheel breathing exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diaphragmatic breathing exercise
Number of subjects: 60
Study: 35943913

Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Adhesive strips
Number of subjects: 75
Study: 34162822

Group type: EXPERIMENTAL
Intervention: Ginger mouthwash (20 ccs three times daily for 14 days)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Aloe vera mouthwash (20 ccs three times daily for 14 days)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Normal saline (control group, 20 ccs three times daily for 14 days)
Number of subjects: 105
Study: 33805040

Group type: EXPERIMENTAL
Intervention: Simplified, combined protocol for severe and moderate acute malnutrition (SAM and MAM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care that treats SAM and MAM separately
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 34977957

Group type: EXPERIMENTAL
Intervention: ART adherence during lockdown
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Well-being scores
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Violence, depression, food insecurity, and stigma
Number of subjects: 152
Study: 33687606

Group type: EXPERIMENTAL
Intervention: Mailed fecal immunochemical test (FIT) outreach program
Number of subjects: 60187

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60187

Group type: EXPERIMENTAL
Intervention: FIT (ordered)
Number of subjects: 60187
Study: 32518932

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg orally 2 hours prior to surgery
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 33155521

Group type: EXPERIMENTAL
Intervention: Family caregiver both at baseline and follow-up (n=74)
Number of subjects: 2294

Group type: EXPERIMENTAL
Intervention: Family caregiver at baseline but not at follow-up (n=226)
Number of subjects: 2294

Group type: EXPERIMENTAL
Intervention: Non-caregiver at baseline but family caregiver at follow-up (n=218)
Number of subjects: 2294

Group type: COMPARATOR
Intervention: Non-caregiver both at baseline and follow-up (n=1776)
Number of subjects: 2294
Study: 35762025

Group type: EXPERIMENTAL
Intervention: Urine specific gravity guided fluids
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard parameters for maintaining postnatal weight loss
Number of subjects: 80
Study: 34165503

Group type: EXPERIMENTAL
Intervention: DTP (docetaxel, trastuzumab, and pertuzumab) - 6 cycles
Number of subjects: 202

Group type: COMPARATOR
Intervention: T-DM1 (trastuzumab emtansine) - monotherapy
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: DTP (docetaxel, trastuzumab, and pertuzumab)
Number of subjects: 202

Group type: COMPARATOR
Intervention: T-DM1 (trastuzumab emtansine)
Number of subjects: 202
Study: 35128627

Group type: EXPERIMENTAL
Intervention: Scalloped bleaching tray cutout
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nonscalloped bleaching tray cutout
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (scalloped and nonscalloped)
Number of subjects: 120
Study: 33234048

Group type: EXPERIMENTAL
Intervention: Expert physical therapist (PT) as reference standard for joint mobilization
Number of subjects: 24
Study: 35742445

Group type: EXPERIMENTAL
Intervention: TENS plus SFE
Number of subjects: 68

Group type: COMPARATOR
Intervention: SFE alone (with sham TENS)
Number of subjects: 68
Study: 34378517

Group type: EXPERIMENTAL
Intervention: Temporarily Implanted Nitinol Device (iTind)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study: 32567941

Group type: EXPERIMENTAL
Intervention: Triticum vulgare (TV) spray, gluten-free, used twice daily after toothbrushing for 2 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no TV spray), enrolled in a mechanical plaque control programme for 2 weeks
Number of subjects: 57
Study: 33768368

Group type: EXPERIMENTAL
Intervention: Fluticasone Propionate Dry Powder Inhaler A-4.5 (500 μg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fluticasone Propionate Dry Powder Inhaler B-3.8 (500 μg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fluticasone Propionate Dry Powder Inhaler C-3.7 (500 μg)
Number of subjects: 24
Study: 35836147

Group type: EXPERIMENTAL
Intervention: Continuous and intermittent hypoxia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 33560777

Group type: EXPERIMENTAL
Intervention: Knee flexor (KF) eccentric exercise
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Knee extensor (KE) eccentric exercise
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group performing elbow flexor (EF) MaxEC
Number of subjects: 52
Study: 32301372

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST) initiated early postoperatively, training at 85‐90% of maximal capacity for 8‐10 weeks (4 × 5 repetitions).
Number of subjects: 42
Study: 34472736

Group type: EXPERIMENTAL
Intervention: Lidocaine-based scalp block and laryngotracheal local anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: General anesthesia only
Number of subjects: 40
Study: 36001881

Group type: EXPERIMENTAL
Intervention: Badges awarded
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Badges not awarded
Number of subjects: 777

Group type: COMPARATOR
Intervention: No badges (control)
Number of subjects: 777
Study: 33462512

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (20 g per day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 32936580

Group type: EXPERIMENTAL
Intervention: Second-generation, whole-heart motion correction algorithm (MC2)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: First-generation coronary artery motion correction algorithm (MC1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard algorithm (STD)
Number of subjects: 42
Study: 35413431

Group type: EXPERIMENTAL
Intervention: Interventional multimodal sleep pathway including nursing‐directed nonpharmacologic measures, low‐dose zolpidem and melatonin at bedtime.
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Interventional multimodal sleep pathway
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (no interventional multimodal sleep pathway)
Number of subjects: 125
Study: 34509197

Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate (17P) 250 mg intramuscularly once per week starting between 16 and 24 weeks of gestation until delivery, stillbirth, or reaching term (37 weeks)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Placebo, administered in the same manner as 17P
Number of subjects: 800
Study: 32084053

Group type: EXPERIMENTAL
Intervention: Positively Smoke Free group therapy
Number of subjects: 331

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 331
Study: 34921572

Group type: EXPERIMENTAL
Intervention: G-CEM ONE (GCO)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: G-CEM ONE Adhesive Enhancing Primer (GCO-AEP) + GCO
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: RelyX Universal (RXU)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal Plus (SUP) + RXU
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: G-MultiPrimer (GMP) + GCO
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SUP + RXU
Number of subjects: 120
Study: 34658589

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrectomy
Number of subjects: 4614
Study: 35989328

Group type: EXPERIMENTAL
Intervention: EV1000 group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 34113979

Group type: EXPERIMENTAL
Intervention: Height-for-age z-score (HAZ) at 2 years
Number of subjects: 1579

Group type: EXPERIMENTAL
Intervention: Faster height gain between 2 and 7 years
Number of subjects: 1579

Group type: EXPERIMENTAL
Intervention: Body-mass-index z-score (BMIZ) at 2 years
Number of subjects: 1579

Group type: EXPERIMENTAL
Intervention: Conditional weight gain between 2 and 7 years
Number of subjects: 1579
Study: 35380121

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32089359

Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 731

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 731
Study: 34694401

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) (n = 667)
Number of subjects: 1188

Group type: COMPARATOR
Intervention: No caloric restriction (NoCR) (n = 521)
Number of subjects: 1188

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 1188
Study: 32367115

Group type: EXPERIMENTAL
Intervention: Human milk-based fortifier (HMBF)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Bovine milk-based fortifier (BMBF)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 64
Study: 34540645

Group type: COMPARATOR
Intervention: Ropivacaine 0.5% 20 mL (Control)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% 20 mL plus 4mg dexamethasone
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% 20 mL plus 75 mcg dexmedetomidine
Number of subjects: 117
Study: 32646850

Group type: EXPERIMENTAL
Intervention: mpMRI-targeted biopsy
Number of subjects: 252
Study: 34366227

Group type: EXPERIMENTAL
Intervention: Brief Health Literacy Screen (BHLS)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Newest Vital Sign (NVS)
Number of subjects: 460
Study: 36460919

Group type: EXPERIMENTAL
Intervention: Selective removal to soft dentin with calcium silicate-based material (CS)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Selective removal to soft dentin without calcium silicate-based material (CS)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Selective removal to firm dentin (control)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Pulp exposure (PE) group
Number of subjects: 134
Study: 33649375

Group type: EXPERIMENTAL
Intervention: Hierarchical deep learning model using transfer learning with small datasets
Number of subjects: 954

Group type: EXPERIMENTAL
Intervention: Hierarchical deep learning model
Number of subjects: 954

Group type: COMPARATOR
Intervention: Flat classification method
Number of subjects: 954
Study: 32096324

Group type: EXPERIMENTAL
Intervention: Erbium: YAG (Er:YAG) laser with RecoSMA technology
Number of subjects: 112
Study: 35469957

Group type: EXPERIMENTAL
Intervention: IN.PACT AV DCB
Number of subjects: 330

Group type: COMPARATOR
Intervention: Standard uncoated PTA
Number of subjects: 330
Study: 32993775

Group type: EXPERIMENTAL
Intervention: ACAT group (Cognitive-behavioral family therapy)
Number of subjects: 48

Group type: COMPARATOR
Intervention: TAU group (treatment-as-usual)
Number of subjects: 48
Study: 34112180

Group type: EXPERIMENTAL
Intervention: CT-based rad-score for predicting pathological complete response (pCR)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: CT-based rad-score for predicting pCR
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Combined model of CT- and MRI-based radiomic signatures
Number of subjects: 177
Study: 32624472

Group type: EXPERIMENTAL
Intervention: Reduced imaging strategy (radiographs at 6 and 12 weeks only for clinical indication)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Usual care (routine radiography at 1, 2, 6 and 12 weeks)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Reduced imaging strategy
Number of subjects: 341

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 341
Study: 33749294

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Alcohol and Cannabis Education (ACE)
Number of subjects: 448
Study: 35000949

Group type: EXPERIMENTAL
Intervention: G‐Premio Bond/self‐etch technique
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: G‐Premio Bond/total‐etch technique
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: G‐Premio Bond/selective‐etch technique
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond/self‐etch technique
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond/selective‐etch technique
Number of subjects: 70
Study: 34229042

Group type: EXPERIMENTAL
Intervention: Video game training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Motor-cognitive dual-task training
Number of subjects: 60
Study: 35412528

Group type: EXPERIMENTAL
Intervention: Overminus spectacles
Number of subjects: 386

Group type: COMPARATOR
Intervention: Nonoverminus spectacles
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Both treatment groups combined
Number of subjects: 386
Study: 34413169

Group type: EXPERIMENTAL
Intervention: LPV7+Tet+IFA+polyICLC
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: IFA-containing adjuvants
Number of subjects: 50

Group type: COMPARATOR
Intervention: TLR agonists only
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Full-length LPV7
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tet
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: LPV7
Number of subjects: 50
Study: 32795098

Group type: EXPERIMENTAL
Intervention: Cangrelor (n=40)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Tirofiban (n=40)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Chewed Prasugrel (n=21)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Integral Prasugrel (n=21)
Number of subjects: 122
Study: 34079520

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 32345990

Group type: EXPERIMENTAL
Intervention: Indacaterol
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 35762124

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction Therapy (BFR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard rehabilitation (CONTROL)
Number of subjects: 32
Study: 32711800

Group type: EXPERIMENTAL
Intervention: Emtricitabine (200 mg) and tenofovir alafenamide (25 mg) daily
Number of subjects: 5387

Group type: COMPARATOR
Intervention: Emtricitabine (200 mg) and tenofovir disoproxil fumarate (300 mg) daily
Number of subjects: 5387

Group type: EXPERIMENTAL
Intervention: Emtricitabine and tenofovir alafenamide
Number of subjects: 5387

Group type: COMPARATOR
Intervention: Emtricitabine and tenofovir disoproxil fumarate
Number of subjects: 5387

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 5387
Study: 35181698

Group type: EXPERIMENTAL
Intervention: FePO4-NP (specific surface area 98 m2g-1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FePO4-NP (specific surface area 188 m2g-1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: FeSO4
Number of subjects: 0
Study: 33485147

Group type: EXPERIMENTAL
Intervention: Horizontal spring-loaded countermovement jumps
Number of subjects: 9
Study: 33326434

Group type: EXPERIMENTAL
Intervention: End-effector gait robot (EEGR) rehabilitation program (200 steps, 3 times a day for 5 weekdays)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: End-effector gait robot (EEGR) rehabilitation program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Walker on floor (WF)
Number of subjects: 20
Study: 35677967

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Capillary Self-Monitoring of Blood Glucose (SMBG)
Number of subjects: 116
Study: 34293528

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (IgPro20) at 0.2 g/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (IgPro20) at 0.4 g/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32780166

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (50 mg/kg, maximum single dose 3 g) and thiamine (200 mg) every 12 h for 48 h
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo (0.9% saline with the same protocol)
Number of subjects: 111
Study: 35617333

Group type: EXPERIMENTAL
Intervention: Resistance training (15 weeks, 3 times per week)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 65
Study: 34803068

Group type: EXPERIMENTAL
Intervention: Asthma Self Management Knowledge Questionnaire scores
Number of subjects: 221
Study: 36283897

Group type: EXPERIMENTAL
Intervention: 4vHPV vaccine
Number of subjects: 1680

Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Number of subjects: 1680

Group type: COMPARATOR
Intervention: Gardasil 4 (control)
Number of subjects: 1680
Study: 33097017

Group type: EXPERIMENTAL
Intervention: Probiotic containing Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 34435513

Group type: EXPERIMENTAL
Intervention: 5 mg·kg‐1 caffeine (CAF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 5 mg·kg‐1 placebo (PLA)
Number of subjects: 28
Study: 35469973

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop system (CamAPS FX)
Number of subjects: 33